Propranolol
"Propranolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
Descriptor ID |
D011433
|
MeSH Number(s) |
D02.033.100.624.698.711 D02.033.755.624.698.711 D02.092.063.624.698.711 D02.455.426.559.847.638.945 D04.615.638.945
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propranolol".
Below are MeSH descriptors whose meaning is more specific than "Propranolol".
This graph shows the total number of publications written about "Propranolol" by people in this website by year, and whether "Propranolol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 2 | 2 | 2000 | 0 | 1 | 1 | 2001 | 0 | 3 | 3 | 2002 | 0 | 1 | 1 | 2004 | 1 | 1 | 2 | 2005 | 0 | 1 | 1 | 2007 | 1 | 1 | 2 | 2008 | 0 | 1 | 1 | 2009 | 0 | 1 | 1 | 2010 | 2 | 0 | 2 | 2011 | 1 | 1 | 2 | 2013 | 2 | 0 | 2 | 2014 | 2 | 0 | 2 | 2018 | 0 | 2 | 2 | 2019 | 1 | 0 | 1 | 2020 | 0 | 1 | 1 | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Propranolol" by people in Profiles.
-
Braun M, Metry D, Frieden IJ, Antaya RJ, Mancini AJ, Kohn LL. Persistent dysesthesias in involuted infantile hemangiomas: An uncommon complication in a common condition. Pediatr Dermatol. 2021 Sep; 38(5):1061-1065.
-
Liao P, Song K, Zhu Z, Liu Z, Zhang W, Li W, Hu J, Hu Q, Chen C, Chen B, McLeod HL, Pei H, Chen L, He Y. Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8+ T Cells and Inhibiting Tumor AKT/MAPK Pathway. Clin Pharmacol Ther. 2020 09; 108(3):606-615.
-
Park BD, Lyn-Kew K, Granchelli A, Mehta A. A 62-Year-Old Woman With Diffuse Myalgias, Fatigue, and Shortness of Breath. Chest. 2020 03; 157(3):e75-e78.
-
Droho S, Cuda CM, Perlman H, Lavine JA. Monocyte-Derived Macrophages Are Necessary for Beta-Adrenergic Receptor-Driven Choroidal Neovascularization Inhibition. Invest Ophthalmol Vis Sci. 2019 12 02; 60(15):5059-5069.
-
Silverman E, Haber LA, Geha RM. Lift Then Shift: Thyrotoxic Periodic Paralysis. Am J Med. 2019 01; 132(1):e3-e6.
-
Levin MD, Saitta SC, Gripp KW, Wenger TL, Ganesh J, Kalish JM, Epstein MR, Smith R, Czosek RJ, Ware SM, Goldenberg P, Myers A, Chatfield KC, Gillespie MJ, Zackai EH, Lin AE. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients. Am J Med Genet A. 2018 08; 176(8):1711-1722.
-
Schroeppel TJ, Croce MA, Fabian TC. Re: Paroxysmal sympathetic hyperactivity, traumatic brain injury, and ?-blockers: Not all drugs are created equal. J Trauma Acute Care Surg. 2014 Aug; 77(2):387-8.
-
Schroeppel TJ, Sharpe JP, Magnotti LJ, Weinberg JA, Clement LP, Croce MA, Fabian TC. Traumatic brain injury and ?-blockers: not all drugs are created equal. J Trauma Acute Care Surg. 2014 Feb; 76(2):504-9; discussion 509.
-
Schneider AM, Simson PE, Daimon CM, Mrozewski J, Vogt NM, Keefe J, Kirby LG. Stress-dependent opioid and adrenergic modulation of newly retrieved fear memory. Neurobiol Learn Mem. 2014 Mar; 109:1-6.
-
Wilson J, Higgins D, Hutting H, Serkova N, Baird C, Khailova L, Queensland K, Vu Tran Z, Weitzel L, Wischmeyer PE. Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis. Crit Care. 2013 Sep 10; 17(5):R195.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|